Koons on Pfizer Agreeing to Buy Medivation (A...

Brad Smith, President of Microsoft, discusses updated content from his book "Tools and Weapons: The Promise and the Peril of the Digital Age." Jennifer Surane, Finance Reporter for Bloomberg News, talks about her story, "Wall Street Limps Into Post-Labor Day Return Derailed by De ...  Show more

Phil Orlando, Chief Equity Market Strategist and Head of Client Portfolio Management at Federated Hermes, talks jobs and markets. Skylar Woodhouse, Reporter for Bloomberg News, discusses the aftermath of Hurricane Ida in New York City. Tom Bohn, President & CEO of the Association ...  Show more

Bloomberg BNA's Eleanor Tyler joins Tom Keene and Mike McKee to discuss pharmaceutical mergeres, tax inversions, drug pricing, and the renewed efforts by the Federal Trade Commission to regulate an increasingly complicated industry. Learn more about your ad-choices at https://www ...  Show more

In the first of two episodes this week, we're taking a deep dive into the pharmaceutical industry.

How much does the medication you take actually cost? What if a company came along and bought the rights to a particular drug and started charging double, triple, or even 1 ...

Ireland-based biopharmaceutical company Jazz Pharmaceuticals buys the biggest acquisition in the cannabis industry to date after agreeing to buy GW Pharmaceuticals for $7.2 billion last week. Learn more about your ad-choices at https://www.iheartpodcastnetwork.comSee omnystudio.c ...  Show more

In today's episode, we discuss issues in the pharmaceutical industry, how pharmacists are dealing with the pandemic, and how the role of the pharmacist is evolving. "If you don't want to be in the business of serving, then get out of pharmacy." - Todd Eury Take the Corepreneur Se ...  Show more